This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hruby, D. E. Articles by Kates, J. R. Search for Related Content PubMed PubMed Citation Articles by Hruby, D. E. Articles by Kates, J. R.

 Previous Article  |  Next Article 

J Virol. 1979 February; 29(2): 705-715

Vaccinia Virus Replication I. Requirement for the Host-Cell Nucleus

¹ Department of Microbiology, Health Sciences Center, State University of New York, Stony Brook, New York 11794
² Department of Pharmacology, Health Sciences Center, State University of New York, Stony Brook, New York 11794

ABSTRACT

Using cytochalasin B-induced enucleation techniques, we examined the ability of vaccinia virus to replicate in the absence of the host-cell nucleus in several mammalian cell lines. It was found that virus-infected enucleated cells (cytoplasts) prepared from BSC-40, CVC, and L cells were incapable of producing infectious progeny virus. The nature of this apparent nuclear involvement was studied in detail in BSC-40 cells. Modulations designed to maximize cytoplast integrity and longevity, such as reduction of the growth temperature and initial multiplicity of infection, did not improve virus growth in cytoplasts. Sodium dodecyl sulfate-polyacrylamide gel analysis of the [³⁵S]methionine pulse-labeled proteins synthesized in vaccinia virus-infected cytoplasts demonstrated that both early and late viral gene products were being expressed at high levels and with the proper temporal sequence. Vaccinia virus cytoplasmic DNA synthesis, as measured by [³H]thymidine incorporation, peaked at 3 h postinfection and was 70 to 90% of control levels in cytoplasts. However, in the cytoplasts this DNA was not converted to a DNase-resistant form late in infection, which was consistent with the failure to isolate physical particles from infected cytoplasts. Treatment of vaccinia virus-infected cells with 100 µg of rifampin/ml from 0 to 8 h to increase the pools of viral precursors, followed by subsequent removal of the drug, resulted in a threefold increase virus yield. This treatment had no effect on virus-infected cytoplasts. Finally, vaccinia virus morphogenesis was studied under an electron microscope in thin sections of virus-infected cells and cytoplasts which had been prepared at various times during a single-step growth cycle. It was apparent that, although early virus morphogenetic forms appeared, there was no subsequent DNA condensation or particle maturation in the cytoplasts. These results suggest that vaccinia virus requires some factor or function from the host-cell nucleus in order to mature properly and produce infectious progeny virus.

This article has been cited by other articles:

• Berhanu, A., Wilson, R. L., Kirkwood-Watts, D. L., King, D. S., Warren, T. K., Lund, S. A., Brown, L. L., Krupkin, A. K., VanderMay, E., Weimers, W., Honeychurch, K. M., Grosenbach, D. W., Jones, K. F., Hruby, D. E. (2008). Vaccination of BALB/c Mice with Escherichia coli-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge. J. Virol. 82: 3517-3529 [Abstract] [Full Text]  
• Alzhanova, D., Hruby, D. E. (2006). A trans-Golgi Network Resident Protein, golgin-97, Accumulates in Viral Factories and Incorporates into Virions during Poxvirus Infection. J. Virol. 80: 11520-11527 [Abstract] [Full Text]  
• Byrd, C. M., Bolken, T. C., Mjalli, A. M., Arimilli, M. N., Andrews, R. C., Rothlein, R., Andrea, T., Rao, M., Owens, K. L., Hruby, D. E. (2004). New Class of Orthopoxvirus Antiviral Drugs That Block Viral Maturation. J. Virol. 78: 12147-12156 [Abstract] [Full Text]  
• Hedengren-Olcott, M., Byrd, C. M., Watson, J., Hruby, D. E. (2004). The Vaccinia Virus G1L Putative Metalloproteinase Is Essential for Viral Replication In Vivo. J. Virol. 78: 9947-9953 [Abstract] [Full Text]  
• Byrd, C. M., Bolken, T. C., Hruby, D. E. (2003). Molecular Dissection of the Vaccinia Virus I7L Core Protein Proteinase. J. Virol. 77: 11279-11283 [Abstract] [Full Text]  
• Lemm, J. A., Bergqvist, A., Read, C. M., Rice, C. M. (1998). Template-Dependent Initiation of Sindbis Virus RNA Replication In Vitro. J. Virol. 72: 6546-6553 [Abstract] [Full Text]  
• Grosenbach, D. W., Hruby, D. E. (1998). Analysis of a Vaccinia Virus Mutant Expressing a Nonpalmitylated Form of p37, a Mediator of Virion Envelopment. J. Virol. 72: 5108-5120 [Abstract] [Full Text]  
• Grosenbach, D. W., Ulaeto, D. O., Hruby, D. E. (1997). Palmitylation of the Vaccinia Virus 37-kDa Major Envelope Antigen. IDENTIFICATION OF A CONSERVED ACCEPTOR MOTIF AND BIOLOGICAL RELEVANCE. J. Biol. Chem. 272: 1956-1964 [Abstract] [Full Text]  
• Rajagopal, I., Ahn, B.-Y., Moss, B., Mathews, C. K. (1995). Roles of Vaccinia Virus Ribonucleotide Reductase and Glutaredoxin in DNA Precursor Biosynthesis. J. Biol. Chem. 270: 27415-27418 [Abstract] [Full Text]  
• Zhang, P., Frugulhetti, I., Jiang, Y., Holt, G. L., Condit, R. C., Lee, M. Y. W. T. (1995). Expression of the Catalytic Subunit of Human DNA Polymerase [IMAGE] in Mammalian Cells Using a Vaccinia Virus Vector System. J. Biol. Chem. 270: 7993-7998 [Abstract] [Full Text]